Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Identifying key molecular attributes can help in the risk-adapted treatment of Hodgkin lymphoma and chronic lymphocytic leukemia. At JADPRO Live, presenters reviewed best practices for managing patients with the rapidly expanding armamentarium of treatments for these patients.

Detalles Bibliográficos
Autores principales: Kurtin, Sandra E., McNeill, 1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2018
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333556/
_version_ 1783387568424878080
author Kurtin, Sandra E.
McNeill, 1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey
author_facet Kurtin, Sandra E.
McNeill, 1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey
author_sort Kurtin, Sandra E.
collection PubMed
description Identifying key molecular attributes can help in the risk-adapted treatment of Hodgkin lymphoma and chronic lymphocytic leukemia. At JADPRO Live, presenters reviewed best practices for managing patients with the rapidly expanding armamentarium of treatments for these patients.
format Online
Article
Text
id pubmed-6333556
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-63335562019-02-04 Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Kurtin, Sandra E. McNeill, 1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey J Adv Pract Oncol Meeting Reports Identifying key molecular attributes can help in the risk-adapted treatment of Hodgkin lymphoma and chronic lymphocytic leukemia. At JADPRO Live, presenters reviewed best practices for managing patients with the rapidly expanding armamentarium of treatments for these patients. Harborside Press 2018-04 2018-04-01 /pmc/articles/PMC6333556/ Text en Copyright © 2018, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Meeting Reports
Kurtin, Sandra E.
McNeill, 1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey
Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
title Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
title_full Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
title_fullStr Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
title_full_unstemmed Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
title_short Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
title_sort contemporary management of hodgkin lymphoma and chronic lymphocytic leukemia
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333556/
work_keys_str_mv AT kurtinsandrae contemporarymanagementofhodgkinlymphomaandchroniclymphocyticleukemia
AT mcneill1theuniversityofarizonacancercentertucsonarizona2johntheurercancercenterhackensacknewjersey contemporarymanagementofhodgkinlymphomaandchroniclymphocyticleukemia

Ejemplares similares